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Abstract
Background: Bipolar disorder is a common psychiatric disorder with a massive psychological and social burden.
Research indicates that treatment adherence is not good in these patients. The families’ knowledge about the
disorder is fundamental for managing their patients’ disorder. The purpose of the present study was to investigate
the knowledge of the family members of a sample of Iranian patients with bipolar I disorder (BD-I) and to explore
the potential reasons for treatment non-adherence.
Methods: This study was conducted by qualitative content analysis. In-depth interviews were held and open-
coding inductive analysis was performed. A thematic content analysis was used for the qualitative data analysis.
Results: The viewpoints of the family members of the patients were categorized in five themes, including
knowledge about the disorder, information about the medications, information about the treatment and the
respective role of the family, reasons for pharmacological treatment non-adherence, and strategies applied by
families to enhance treatment adherence in the patients. The research findings showed that the family members
did not have enough information about the nature of BD-I, which they attributed to their lack of training on the
disorder. The families did not know what caused the recurrence of the disorder and did not have sufficient
knowledge about its prescribed medications and treatments. Also, most families did not know about the etiology
of the disorder.
Conclusion: The lack of knowledge among the family members of patients with BD-I can have a significant impact
on relapse and treatment non-adherence. These issues need to be further emphasized in the training of patients’
families. The present findings can be used to re-design the guidelines and protocols in a way to improve treatment
adherence and avoid the relapse of BD-I symptoms.
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Background
Bipolar I disorder (BD-I) is a chronic and recurrent psy-
chiatric disorder in which a person has a manic episode
for 1 week, which may present before or after hypo-
manic or major depressive episodes [1].
BD-I is accompanied by chronic stress, disability, in-
creased risk of sudden mood swings, higher rates of co-
morbid disorders and moral, financial, and legal
problems. The disorder is ranked the sixth debilitating
disease according to the World Health Organization
(WHO). BD-I is considered the most expensive mental
disorder in terms of the health and behavioral care re-
quired by the patients and the burden on governmental
institutions and insurance companies [2–4]. According
to a report by the Central Bank of the Islamic Republic
of Iran, the average annual income of an Iranian house-
hold in 2012 was 209,050,000 Rials. The direct annual
cost of one BD-I patient consists of 10% of this average
family income [5].
BD-I affects the patient’s life and has long-term conse-
quences that are visible in the patient’s social perform-
ance and quality of life [6, 7]. Severe impairment in job
performance is observed in about 30% of the patients
with BD-I. In such cases, functional improvement falls
substantially behind symptom improvement [1].
Pharmacological treatment is the first-line treatment
for BD-I. Evidence shows that about 40% of patients
with BD-I do not have good medication adherence,
which translates into a higher probability of symptom
relapse, hospitalization, and increased suicide risk [8]. In
a study in Tehran, Iran, poor treatment adherence was
noticed in about 30% of BD-I patients [9]. Another study
from Iran [10] also reported the prevalence of poor com-
pliance in BD-I patients after the first episode of mania
as 38.1% during a 17-month follow-up period. Therefore,
it is of great importance to better understand and inves-
tigate the underlying reasons for treatment non-
adherence in BD-I patients.
Given the changes implemented in health care systems
over the last two decades and the resultant focus on
community-based services, the role of families in caring
for BD-I patients has become more prominent [6]. The
insufficient knowledge of families about the disorder, its
symptoms, and medications has made the management
of BD-I more difficult and eventually imposes additional
costs on them [6]. The higher is the cost imposed on the
family, the more likely is it for the family members to
show adverse reactions to the BD-I patients, which itself
leads to a higher chance of disorder relapse [3].
In Iran, the general public is acquainted with various
types of psychiatric illnesses through mass media and
public educational websites such as the website of the
Iranian Psychiatric Association (https://iranmentalhealth.
com) and other Persian public written sources. Patients
with BD-I and their families become familiar with the
treatment process after consulting a general practitioner, a
psychiatrist, or a psychologist, and, if necessary, the pa-
tients are admitted to the hospital through a psychiatrist.
In addition to medical treatment, they receive the neces-
sary training and information about their treatment
process in the hospital. Furthermore, an association called
ABR (Association of Mental Health Promotion), with an
active website (http://abrcharity.ir), independently moni-
tors patients, including those with bipolar disorder, after
discharge.
Many studies have examined the views and roles of pa-
tients with BD-I and their caregivers and also the im-
portance of family awareness and its impact on
medication adherence. Tacchi & Scott [11] and Veligan
et al. [12] suggest that the family members’ beliefs about
the nature of BD-I and the information they have about
the disorder affect the patient’s medication adherence.
The review of literature showed no precise studies con-
ducted to explore the knowledge, information, and opin-
ions of family members of BD-I patients about the
disorder and the causes of their medication non-
adherence.
In a previous study in Iran [13], the authors held quali-
tative interviews with the family members of patients
with BD-I and reported that treatment non-adherence is
a major problem in these patients. They also reported
that the patients and their families did not have suffi-
cient knowledge about the nature of this disorder. Con-
sidering these findings about the insufficient knowledge
of the family members of BD-I patients and the high rate
of treatment non-adherence, it is necessary to conduct
more studies to investigate the possible causes of treat-
ment non-adherence and families’ knowledge and beliefs
about this disorder in Iran. This study was thus carried
out to explore the viewpoints of the family members of
BD-I patients about the nature of this disorder and the
potential causes of treatment non-adherence. The results
can be used for revising the psychoeducation guidelines
for BD-I patients, as clinical guidelines mandate the in-
clusion of psychoeducation in the treatment plan
adopted for these patients. The results can also be used
to design a protocol to address the disorder relapse,
which can have substantial consequences in terms of re-
ducing healthcare costs.
Methods
The findings of this study are reported according to the
Consolidated Criteria for Reporting Qualitative Research
(COREQ) checklist [14].
Study samples’ characteristics
The participants were the family members of patients di-
agnosed with BD-I. The patients had been admitted to
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Iran Psychiatry Hospital in Tehran, Iran, and were re-
ceiving pharmacological treatments.
This study used purposive sampling to select the par-
ticipants. From November 2017 to April 2018, 12 pa-
tients were interviewed by two psychiatrists based on the
DSM-5 criteria [1] and received the diagnosis of BD-I.
Then these diagnoses were confirmed by A.SH. and their
families were invited to participate in the study.
None of the family members refused to participate in
the study and they all completed the entire course of the
study. The mean age of the participants was 50.83 years.
There were three male (25%) and nine female (75%) par-
ticipants (Table 1). Table 2 shows further details on pa-
tients’ characteristics.
Data collection
After diagnosing patients with BD-I, and obtaining the
written consent of the family members of patients to
participate in this study, data were collected by in-depth
interviews from family members of patients, conducted
at the hospital’s conference hall. No one else was present
at the time of the interviews except for the interviewer
and the participant. Each interview lasted approximately
20 min and was digitally recorded for subsequent ana-
lyses. Two female PhD candidates (N. M. and M. N.) in
clinical psychology at the University of Social Welfare
and Rehabilitation Sciences, Tehran, Iran, who had
already received training on the implementation of
qualitative studies, held the interviews. They did not
know any of the participants. The interviewers intro-
duced themselves to the participants before the begin-
ning of each interview. The interview questions were
provided by the authors. The interviews were held only
once and were not repeated. Data saturation was
reached with 12 participants, and no further participants
were interviewed after reaching this number. Data satur-
ation occurs when no new information is obtained by
conducting further interviews [15].
Data analysis
Thematic analysis was used for the qualitative data ana-
lysis [16, 17]. To this end, the six steps proposed by
Clark and Brown [17] were used.
The raw data derived from the interviews were used
for the analysis. The content of the interviews were tran-
scribed verbatim immediately after each interview. Field
notes were made during the interviews and were
reviewed in this stage. Three authors (M. N., N. M., and
Z. T.) read the interviews several times for immersing in
the data and getting familiar with it. Line-by-line coding
was then applied to generate the initial codes. These
steps were performed manually by the three authors
without using any computer programs. One author
encoded each interview and the interview was then read
by another author and encoded again. The individually-
extracted codes were then integrated and modified, if
necessary.
In the next step, by linking the codes together, their
common patterns and concepts were extracted and po-
tential themes and subthemes were identified, keeping
the research questions in mind. The data related to the
themes were then collected and examined to verify the
accuracy of the themes and subthemes, which resulted
in five final themes.
Several statements were selected from the interviews
as examples and are reported in the results section. To
preserve participants’ anonymity, their names and ages
are not mentioned in the results; instead, they are repre-
sented by random numbers.
Results
Taking into account comprehensiveness, homogeneity,
and overlap, the components of the family members’
viewpoints on the nature of the disorder and the reasons
for pharmacological treatment non-adherence were cate-
gorized into five themes, including knowledge about the
disorder, information about the medications, informa-
tion about the treatment and the respective role of the
family, reasons for pharmacological treatment non-
adherence, and strategies applied by families to enhance
treatment adherence in the patients.
Each of the themes contained several subthemes,
which were themselves made up of some open codes.
Table 1 Participants’ demographic characteristics
Participants
(n = 12)
Age, years: mean (SD) range 50.83 (9.73) 36–67
Male: n (%) 3 (25)





Middle school or lower 5 (41.67)
High school 2 (16.7)
Bachelor’s 3 (25)
Master’s or higher 2 (16.8)
Relationship with the patient, n (%)
Patient’s mother 7 (58.3)
Patient’s son 1 (8.3)
Patient’s wife 1 (8.3)
Patient’s husband 1 (8.3)
Patient’s sister 1 (8.3)
Patient’s brother 1 (8.3)
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These subthemes contained recurrent codes and con-
cepts that shared a common meaning.
Table 3 presents the themes, subthemes and examples
of some of the codes.
Theme one: knowledge about the disorder
Most interviewees did not have sufficient or accurate
knowledge about the nature of BD-I, the signs and
symptoms of depression and mania cycles, and the out-
come of the disorder. They mentioned the lack of train-
ing or inadequate training (especially by healthcare
providers) as the main cause of insufficient knowledge
about BD-I. Additionally, most families did not have a
good understanding of the etiology of BD-I.
Some of them considered BD-I as a genetic abnormal-
ity, while others considered factors such as adolescent
maltreatment, parents’ unusual conditions during sexual
intercourse, and the lack of proper training before par-
enthood as potential causes of BD-I.
Participant No. 5 (a patient’s wife): “I was told that
he has a nervous problem.”
Participant No. 3 (a patient‘s mother): "I have a the-
ory about having babies. I think that not everyone
should have children. The husband and wife should
be screened and monitored for two years to see if
they understand the matter clearly. Do you see these
anomalies now? ... These shameful movies they
watch … The person is not feeling well when raising
their kid … From an Islamic point of view, from a
human’s point of view, both the husband and wife
need to be monitored. Their food and other things
should also be monitored to see if they can have a
healthy baby.”
Participant No. 7 (a patient’s mother): "Because this
boy is always impressed by me, sometimes I tell my-
self, maybe I didn’t fully understand him during his
puberty. Sometimes I blame myself, as he has said
this many times. I always blame myself … .
Sometimes he says, ‘You did this to me, that’s why
I’m sick now and take drugs’. For example, when hit-
ting puberty, in the first or second year of high
school, he used to get up late and so he got to school
very late. Then the school’s principal complained to
me, ‘Why is he late again?’ And he says, ‘Why did
you wake me up early in the morning? You did this
to me.”
Participant No. 10 (a patient’s mother), referring to
her son's divorce: "That's why he's so broken.”
Participant No. 11 (a patient’s sister): "Bipolar dis-
order has a genetic background. I think there would
be no one out there who suffered from the disorder
unless they got the genes. It is a genetic disorder, but
it emerges when a patient experiences a series of
shocking events. Well, some have higher potentials,
such as those who get very angry. I mean, the anger
itself is not part of the disorder, but in angry people,
shocking events affect the patient more rapidly.”
Theme two: information about the medications
Many family members had a misconception about the
treatment of the disorder and the effects of psychotropic
medications on the patients. In other words, they were
unable to accurately identify the therapeutic effects of
the administered medications and the time it took for
the patients to show signs of improvement. Also, some
participants were unaware of the side-effects of the pre-
scribed medications. Some mentioned side-effects like












1 1 Daughter Female 20–30 Single Unemployed 8 years Parents
2 2 Son Male 30–40 Single Unemployed 10 years Parents
3 3 Son Male 30–40 Single Unemployed 14 years Mother
4 4 Father Male 60–70 Divorced Unemployed 12 years Nobody
5 5 Husband Male 30–40 Married Supermarket salesperson 3 years Parents and husband
5 10 Son Male 30–40 Married 3 years Parents and wife
6 6 Wife Female 30–40 Married Housewife 10 years Husband and two
children
7 7 Son Male 20–30 Single Unemployed 10 years Mother
8 8 Son Male 20–30 Single Unemployed 4 years Parents and brother
9 9 Son Male Single Unemployed
10 11 Brother Male 30–40 Single Unemployed 16 years Mother and sister
11 12 Brother Male 30–40 Single Real Estate Advisor 8 years Parents
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Table 3 Categories of perspectives of families with type one bipolar disorder concerning the nature of the disease and non-
adherence to treatment
Order Themes Subthemes Code examplesa
1 knowledge about the disorder General knowledge Not knowing the name of the disorder
Knowledge of mania phase
Knowledge of depression phase
Not mentioning depression phase
Lack of knowledge about the outcome of the disorder
Misunderstanding recovery and medication effects






Running away from home
Battering
Tendency to leave home
Insomnia
Grandeur delusion
Having two personality states and
Assuming another person identity








Knowledge about etiology of disorder Genetic abnormality
Family treatment during childhood
Family not being guilty
Lack of proper training of parents before parenthood
Unusual conditions of parents during sexual intercourse
Brain disorder
Mother’s lack of understanding the patient during puberty
Divorcing the spouse
Genetic abnormality in addition to precipitating factors
Insufficient etiological knowledge about disorder
Knowledge about the relapse reasons of
disorder)
Discontinuation of medications
Unemployment and society’s lack of support
Financial problems
Death of the father
2 Information about the
medications
Knowledge about effects of the
administered medications on patient
Reduction in aggression
No reduction in aggression
Reduction in the patient’s omnipotence
Patient’s mood stability




No effect on job functioning
Knowledge about the side effects of
prescribed medications
Medication addiction
Obesity and increased appetite
Increased sleep









3 Information about the treatment Knowledge about the treatment The need to take medications
These patients’ incomplete and lasting recovery
Treatment: the patient being employed
Treatment: exercising
The patient’s need to be monitored by the doctor
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memory loss and drug addiction; however, almost all the
participants believed that pharmacological treatment is
necessary for the patients despite the side-effects.
Participant No. 1 (a patient’s mother): "The problem
of her running away from home with her boyfriend
was a big burden for us, but as the prescribed meds
began to show their effectiveness, this problem was
gradually solved and we finally managed to put up
with her aggressiveness and other problems. That is,
we were saying to ourselves, ‘This is a period of an-
griness; we had better not said this, not done that’...
We thought the medication was working. But now
they’ve told me, ‘No, your patient has not recovered
at all, has not been cured.”
Participant No. 1 (a patient's mother): "Her first
psychiatrist, who has been visiting her for eight years,
was frequently asking if she studies, watches TV or
goes to work at all. ‘Whenever she goes back to these
routines, then she has recovered,’ the therapist would
say. Recently, she’s always been saying, ‘I would love
to go to work’ and so on. Once, her employer told her
to do some cleaning, and she had responded, ‘I’m
not your servant.’ She suddenly broke it off and said,
‘I won’t go to work anymore.’ She didn’t sleep at all,
Table 3 Categories of perspectives of families with type one bipolar disorder concerning the nature of the disease and non-
adherence to treatment (Continued)
Order Themes Subthemes Code examplesa
The medication advantages outweigh its disadvantages
Treatment: The patient participation in educational classes and
development of insight about the disease
The family’s negative perspective on medication
Futility of psychologist and counseling
Treatment: childbearing (wrong)
Treatment: things progressing according to the patient’s wish
4 Information about the role of the
family in the treatment
Calming the patient and sympathizing and empathizing with
him
Not stimulating the patient
Bearing with the patient
Not leaving the patient alone
Encouraging the patient to exercise
Encouraging the patient to go out
Normalization of disorder
Generating hope
Taking the patient to the doctor
Making the house quiet
Breaking up the patient’s drug-use implements
Informing significant others life of patient’s symptoms
Tricking the patient into hospitalization
Comforting the patient and creating a sense guilt in them
5 Reasons for pharmacologic
treatment non-adherence
Relatives’ comments
Comments of the powerful and knowledgeable people
The patient’s worsening symptoms
The patient missing their medications
The patient’s stubbornness and anger toward the family
The family’s non-familiarity with the disorder and the treat-
ment process
The patient’s negative ideations about medications
Medication side-effects affecting the patient’s appearance
Medication side-effects affecting the patient’s functioning
Permanent change of the patient’s doctor by the family
TV celebrity talks about futility of medications
Not visiting the doctor during new year holidays
The patient not being annoyed by the symptoms during
mania phase
Using alcohol
Lack of insight about their own disorder
Absence of a family member to help the patient with taking
medications
Family not agreeing to look after the patient
The patient not waking to take their medications
Relative’s disagreement with the patient and their
stubbornness
aTo keep the Table brief, only some repetitive codes in the subthemes are mentioned in the column called code examples
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saying, ‘I work so much, but I don’t feel exhausted at
all.’ We were also excited and thought ‘Yeah, so this
doctor's meds have been good; she’s getting back to
normal, she’s working,’ She was frequently organizing
her closet, like an obsession.”
Participant No. 3 (a patient’s mother): “I can’t re-
member the side-effects but I’ve heard about them in
classes. My daughter is taking lithium now but she
gets these chills. Her stomach is not well. Its side-
effects are such that they affect her memory. How-
ever, when we compare the pros and cons, we have
to take it. "
Theme three: information about the treatment
The regular intake of medications, stress control, work,
exercise, regular visits to a psychiatrist or psychologist,
and the need to provide insight into the patient’s illness
through education were noted by the families in this
part. Some participants believed that psychotherapy ses-
sions cannot help treat this disorder while some had
completely false or superstitious beliefs about treatment
of the disorder.
Participant No. 4 (a patient's son): "Our patient
doesn’t accept justifications. When you bring them to
classes and convince them that ‘You are sick, and
you have to take this medication because of this and
that, and we have evidence that you have this dis-
order,’ and then we show it to them, prove it like in
the movies, say that this disorder is serious because
of so and so reasons, I think, it would be much
easier.”
Participant No. 1 (a patient’s mother): "They sent us
to get counseling. Of course, my daughter did not co-
operate and didn’t come with. So, I got an appoint-
ment under my name to get information and find
out how to deal with this disorder. Then the psych-
ologist said, 'No, your daughter is diagnosed with bi-
polar disorder; this is an acute illness. Counseling
does not work for her. She should take medications –
a lot of them. And since the doc said those words, we
withdrew from counseling altogether.”
Participant No. 5 (a patient’s wife): "My mother-in-
law says, ‘If God gives him a baby, he’ll be fine.’ Be-
cause his ex-wife also failed to bear a child for him.”
Theme four: information about the role of the family in
the treatment
Most families defined their role as helping the patient
recover and adhere to their treatment, reminding
them to take the medications, encouraging them to
go to the doctor, not leaving them alone, and doing
whatever they wanted to do so that things went as
the patient wished. The patients also appeared to feel
guilty when their families tried to comfort them, and
this pattern was observed in several of the partici-
pants in this study.
Participant No. 6 (a patient’s husband): "We should
put up with her, love her, not argue about what she
says, listen to her, get her to do exercise to keep busy.
I'm here now and I brought her with me too instead
of leaving her alone to think about stuff.”
Participant No. 2 (a patient’s mother): "You should
be good to them, listen to them, make home a peace-
ful environment, and not argue.”
Participant No. 8 (a patient’s wife): “I don't know. If
he just thinks that everything is okay, all will be
okay; but such feelings don’t last forever.”
Participant No. 2 (a patient’s mother): "I tell him to
take his meds on time … Say, ‘Let's go to the park to
take a look around ... Don't stay at home too much.
God is merciful; it won’t be that bad’ … I talk to
him, I comfort him sometimes, tell him that I’m ill
too because I feel your pain.’ I really do. I’ve been
crying alone at home many times. God, what will
happen at the end?"(She cries).
Theme five: reasons for pharmacological treatment non-
adherence
As for this theme, the participants noted issues that were
mostly about the comments made by other people, in-
cluding relatives or care-providers, such as doctors or
specialists in other disciplines. An interesting observa-
tion was made by a participant who mentioned a celeb-
rity talking on TV about the inefficiency of medications;
following these comments, the patient had stopped tak-
ing his medications. Another issue was that the families’
constant changing of the patient’s physician contributed
to their medication non-adherence. Another reason
noted for non-adherence was that the patients did not
suffer from mania symptoms and found that it was not
so crucial for them to take the medications. Additionally,
some patients reported the physical discomfort and
weakness (e.g., impotence) experienced as side-effects of
the prescribed medications a reason for their medication
non-adherence.
Participant No. 2 (a patient’s mother): "She didn't
take the meds for seven to eight months. Her friend
had told her ‘Your eyes look different. When you take
the medicine, your eyes turn into a strange shape.
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Get rid of them.’ After seven months, her disease
relapsed.”
Participant No. 6 (a patient’s husband): "If we go to
a party somewhere and someone asks her, ‘Oh, you
take drugs?’ … But that person is not aware of the
matter, cause she might look all well, and that per-
son doesn’t know what’s actually happening in my
wife’s mind, who then has to admit that she is
alright."
Participant No. 7 (a patient’s mother): "At one point
at work, some colleagues told him, ‘You will become
addicted to the medicines, you will get sick.’ Then,
he put the medicines aside and became pessimistic
about his work. ‘This job has made me sick,’ so he
said and left his job all of a sudden. He had a great
job, not a difficult one. He could manage it by him-
self very easily.”
Participant No. 3 (a patient’s mother): “My son had
gone to a doctor to remove the corn on his feet. The
doctor had checked his medicine prescriptions and
asked, ‘What are these you’re taking? You won’t be
able to conceive a baby in the future. It’ll affect you
poorly’ and so on. My son keeps repeating what the
doctor told him.”
Participant No. 1 (a patient’s mother): "That emer-
gency nurse who came to our house told us to change
her doctor. Since then, she has kept repeating this
sentence. She threw out all her medicines.”
Participant No. 3 (a patient’s mother): “Since the be-
ginning of the new year, he’s began to no longer take
his medications. In Khandevaneh,1 Mr. Mehran
Ghafourian (a famous Iranian actor) said, ‘I was in
a bad mood ... I had depression. I put the medica-
tions aside and started exercising.’ My son stopped
taking his medicines on hearing those words. I asked
him many times to go see a doctor but he said no.
He continued to not take his medicines and then his
disorder worsened. He was frequently beating us up
until we took him to the hospital with the help of the
police.”
Participant No. 3 (a patient’s mother): “There was a
child psychiatrist on a TV talk. We took our son to
her office. We used to visit a counselor as well. The
psychiatrist prescribed him some medications. We
didn’t know what the medications were. He was tak-
ing his medicines. In the middle of therapy, we
stopped it. Then, my son-in-law, who is a doctor,
said ‘Dr. A -his professor- is a very good doctor.’ My
son used to go to Dr. A. earlier when he was a col-
lege student. He was taking medicines and he be-
lieved in him so much. Then again, my eldest
daughter, who is a physician, said ‘Dr. B. is a very
helpful therapist. All the doctors, engineers, and edu-
cated people go to visit him.’ Then he went there ...
And two years ago, I took him to Dr. S. too, to help
him get rid of his substance abuse." (This participant
named seven different doctors).
Participant No. 4 (a patient’s son) discussed the rea-
sons for the patient’s refusal to take the medications
and said: "Well, he doesn't actually believe in the
disorder being a real one (in the manic episode).
Maybe now he takes the pill in front of you, but you
know that it is not something that bothers him. You
take pills more easily if you have actual pain, but
when you don’t, you ask yourself ‘Why do I have to
take all these pills?”
Participant No. 11 (a patient’s sister): “We can note
the poor behaviors of those around him. He considers
any weaknesses he experiences (e.g., sexual problems)
a side-effect of the medicines he’s taking. And he’s
linking everything to the medicines and thinking
they’re going to make him different from the others.”
Discussion
The findings of this study regarding the viewpoints of
the family members of patients with BD-I were catego-
rized into five themes. Although qualitative studies do
not allow for the identification of the extent and relative
importance of every condition, recurrent themes and
concepts stated by the participants at different individual
and social levels were extracted.
Research suggests that there is a relationship between
families’ knowledge and beliefs about the disorder and
the patients’ medication adherence [12]. The attitudes
and knowledge of the family members have a significant
influence on the patient’s own beliefs and attitudes and
affect the patient’s decision about treatment compliance
[18]. In agreement with previous studies [19, 20], the
family caretakers in this study were shown to lack suffi-
cient information and knowledge about the nature of
BD-I. In addition, many participants had inaccurate or
false information and insisted on these false beliefs. A
review study on treatment acceptance found that brief
interventions focused on relapse prevention and
psychoeducation-based interventions have the greatest
impact on relapse prevention [21]. Maintaining the pa-
tients’ circadian rhythms (especially sleep rhythm), con-
trolling activity levels, verifying and controlling initial1A popular comedy show on Iranian television
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symptoms of mania and depressive episodes, and not
using narcotics or stimulants have been recommended
in approved psychotherapy protocols for bipolar patients
[22]. Nonetheless, the participants in this study did not
discuss any of these important factors. The lack of
knowledge about these important issues among families
can have a significant impact on relapse and treatment
non-adherence in the patients. These points need to be
further emphasized in training patients’ families.
In a qualitative study on bipolar patients and their
families, Peters, Pontin, Lobban, and Morriss [23]
found that the viewpoints of patients and their fam-
ilies play an important role in managing the disorder;
however, the families usually get despondent about
participating in this process, and their perception was
that some mental health workers believe that family
involvement makes their work more complicated.
Meanwhile, the present study showed that, in Iran,
families do not have enough information about their
role in preventing disorder relapse and attribute their
patient’s relapse only to factors such as medication
withdrawal, unemployment, lack of community sup-
port, and financial problems. Most of them believed
that if everything goes as the patient wishes, the dis-
order will not relapse.
Furthermore, the participants did not have adequate
information about the non-pharmacological treatment
options available for this disorder and the role that psy-
chologists can play in helping the patients enhance their
medication adherence and prevent the symptoms of re-
lapse. A variety of behavioral, cognitive, and emotion-
focused interventions are used in the management of bi-
polar disorders [22]. Nevertheless, the participants did
not have sufficient knowledge about these treatments.
The observation that many psychologists in Iran appear
unwilling to participate in the treatment of bipolar dis-
order patients seems to play a role in this lack of know-
ledge. According to Farhoudian et al. [24], only about
1.5% of all the studies on psychiatric disorders con-
ducted in Iran between 1973 and 2003 involved bipolar
and cyclothymic patients. In a qualitative study on
bipolar-II patients and their families, Fisher et al. [25]
found that the number of resources available to patients
for deciding about their treatment has increased and
their priorities have been given increasing attention; yet,
the patients’ and their families’ preferences are not fully
considered.
Similar to the studies carried out by Jönsson, Wijk,
Skärsäter & Danielson [26] and Shamsaei, Mohamad
Khan Kermanshahi, and Vanaki [27], in the present
study, the patients and their families were struggling
with the acceptance, understanding, and management of
the disorder. According to the participants, the families’
lack of insight into the patients’ disorder contributed
significantly to their medication non-adherence. This
finding is in line with Scott and Pope’s [28] research, but
Delmas, Proudfoot, Parker, and Manicavasagar [29]
stated that the rejection of treatment is a complex issue
that depends on various factors.
Some of the results of this study are consistent with the
findings reported by Clatworthy, Bowskill, Rank, Parham,
and Horne [8], who noted that deliberate treatment non-
adherence is associated with factors such as patients’
concerns about the prescribed medications and their side-
effects in the case of continuous consumption. Proudfoot
et al. [30] stated that the side-effects of medications, cop-
ing with unpleasant symptoms, the extent of awareness
about the nature of the disorder, and the reactions to it as
well as the stigma associated with the disorder affect the
patient’s life path. Besides, these symptoms have a per-
manent impact on the disorder relapse [31]. The findings
showed that the interaction of the disorder, patient, medi-
cations, psychiatric attitude, and cultural attitude with
non-compliance is very complex [32].
In addition to the themes mentioned, there were
some interesting results concerning the response
process in all the interviews. For example, the major-
ity of the participants only reported symptoms of the
manic episode, while two major studies [33, 34] have
shown that people with bipolar I and II (especially
type II) disorders spend most of their symptomatic
days with depression. Patients suffer greatly during
the depressive episodes but have elevated or irritable
moods during the manic episode; in contrast, families
find the mania symptoms more annoying and disrup-
tive to themselves. This duality can negatively impact
reaching a common understanding with the patient
about visiting the doctor and taking medications.
Moreover, the fact that some families do not have
enough information about the depressive episode can
eventuate in neglecting the patient’s need to take
medications during this phase, which can then ad-
versely affect medication adherence. These results are
somewhat contradictory to the results of a previous
study [29], which reported that both patients and
their family members report symptoms of mania and
hypomania to their physicians less often, as some of
them enjoy the manic symptoms. Family members
feel relieved when they see that their patient is happy
and shows mania symptoms. A major cause of this
discrepancy in findings may be the differences in the
study populations. While Delmas et al. [29] studied
patients with bipolar I and II, the present study ex-
amined only patients with BD-I. The discrepancy may
also partially originate from cultural differences. It
seems that when there is a pattern of greater atten-
tion to objective and apparent symptoms, very im-
portant mental symptoms such as suicidal thoughts,
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whether during the mania or depressive episode, are
neglected by families.
This study showed that families with a higher educa-
tional and socioeconomic status tend to seek psychiatric
care from different psychiatrists. Frequently changing
the treating psychiatrist can cause treatment non-
adherence in the patients. Furthermore, as the family
members of such patients falsely think that they have
greater medical information, they are more likely to en-
courage the patient to stop taking their prescribed
medications.
A major limitation of this study was that most par-
ticipants were the mothers of the patients, as it was
hard to find other family members of the patients to
participate in the study. For example, only one child
of a patient and one sister were among the partici-
pants. Also, all the participants were from Tehran
and were selected from one hospital; therefore, the
generalization of the results to other cities in Iran
should be pursued with caution.
Conclusion
The authors suggest using the findings of this quali-
tative study regarding the knowledge of the family
members of patients with bipolar I disorder (BD-I)
as well as the dominating cultural beliefs to design
further quantitative studies. The quantitative assess-
ment of individual, familial, and social reasons for
treatment non-adherence is also a recommendation
for future research. Conducting similar studies on
the family members of patients with other types of
bipolar disorder with an attention to the different
processes and outcomes involved is also recom-
mended. Since there are different ethnicities and
subcultures in Iran, the results obtained by examin-
ing the residents of the country’s capital city cannot
be generalized to the population of other cities and
towns, and it is necessary to repeat the study in
other populations in order to get familiar with other
viewpoints in Iran.
Overall, the results of this study contribute to the
emerging qualitative research on bipolar disorder and
provide the readers with an insight into the viewpoints
of the family members of patients with BD-I. Some in-
accurate information might have been observed in par-
ticipants’ statements due to some deeply-rooted cultural
attitudes and beliefs and their correction may require ex-
tensive interventions.
The results of this study can be used to compile
educational content for patients with bipolar disorder
and their families as well as for psychologists, psychi-
atrists, psychiatry assistants, and hospital health
workers.
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